The World Health Organization (WHO) has given emergency use authorization to a Covid-19 vaccine manufactured by China’s Sinopharm, making it the sixth such inoculation to receive the agency’s green light.
The approval of the jab, which was developed with the Beijing Institute of Biological Products, is for all adults aged 18 and over with a two-dose regimen.
The vaccine demonstrated an overall efficacy against Covid-19 of 78.1% in international phase 3 clinical trials and 78.7% efficacy in preventing hospitalization, according to WHO data.
“This afternoon, WHO gave emergency use listing to Sinopharm Beijing’s Covid-19 vaccine, making it the sixth vaccine to receive WHO validation for safety, efficacy and quality,” the health agency’s Director General Tedros Adhahom Ghebreysus said on Friday. (RT)
Whatsapp xəttimiz - 070 224 40 25